Found 459 matching trials
Study to Assess the Effectiveness of RCHOP With or Without VELCADE in Previously Untreated Non-Germinal Center B-Cell-like Diffuse Large B-Cell Lymphoma Patients PHASE2 This is a randomized, open-label, multi-center, phase 2 study of RCHOP with...
Show More Location
Tower Cancer Research Foundation
Learn More & Join Trial
Use of Thalidomide, Lenalidomide, Carfilzomib, Bortezomib and Vorinostat in the Initial Treatment of Newly Diagnosed Multiple Myeloma Patients PHASE3 The purpose of this study is to compare a standard chemotherapy regimen of ...
Show More Location
112 sites UK wide
Treatments Being Tested
Induction (intensive pathway) - cyclophosphamide, lenalidomide, & dexamethasone (CRD) regimen Induction (intensive pathway) - cyclophosphamide, thalidomide, & dexamethasone (CTD) regimen Induction (intensive pathway) - carfilzomib, cyclophosphamide, lenalidomide, & dexamethasone (CCRD) regimen Induction (non-intensive pathway) - cyclophosphamide, lenalidomide, & dexamethasone attenuated (CRDa) regimen Induction (non-intensive pathway) - cyclophosphamide, thalidomide, & dexamethasone attenuated (CTDa) regimen Consolidation (intensive & non-intensive pathways) - bortezomib, cyclophosphamide, & dexamethasone (VCD) regimen Maintenance (intensive & non-intensive pathways) - lenalidomide maintenance Maintenance (intensive & non-intensive pathways - protocol v5.0 only) - lenalidomide plus vorinostat maintenance High dose melphalan therapy and autologous stem cell transplant (intensive pathway only) Learn More & Join Trial
A Phase I Trial of Bortezomib and Sunitinib PHASE1 The purpose of this study is to test the effect of the combination of sunit...
Show More Location
Emory University Winship Cancer Institute
Learn More & Join Trial
Study of Bendamustine Combined With Bortezomib for Patients With Relapsed/Refractory Multiple Myeloma PHASE1 The primary objective of this study is to assess the safety and tolerabilit...
Show More Location
Pacific Oncololgy & Hematology
Learn More & Join Trial
Tanespimycin and Bortezomib in Treating Patients With Advanced Solid Tumors or Lymphomas PHASE1 This phase I trial is studying the side effects and best dose of giving tan...
Show More Learn More & Join Trial
Belantamab Mafodotin or Daratumumab With Bortezomib, Lenalidomide and Dexamethasone for Newly Diagnosed Multiple Myeloma PHASE3 Eligible participants with newly diagnosed myeloma who are not considered e...
Show More Location
Gundersen Lutheran
Learn More & Join Trial
Bendamustine and Bortezomib Combination Therapy in Indolent Non-Hodgkin's Lymphoma(NHL) PHASE1 The purpose of this study is to determine whether the combination of bendam...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study Comparing JNJ-68284528, a CAR-T Therapy Directed Against B-cell Maturation Antigen (BCMA), Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) or Daratumumab, Pomalidomide and Dexamethasone (DPd) in Participants With Relapsed and Lenalidomide-Refractory Multiple Myeloma PHASE3 The purpose of this study is to compare the efficacy of ciltacabtagene auto...
Show More Status
Active Not Recruiting
Location
University of Alabama at Birmingham
Learn More & Join Trial
CM336 Plus Isa-VR in Newly Diagnosed Primary Plasma Cell Leukemia PHASE2 The goal of this clinical trial is to learn whether CM336, a BCMA/CD3 bispe...
Show More Location
Institute of Hematology and Blood Diseases Hospital Chinese Academy of Medical Sciences
Learn More & Join Trial
Phase II Study of "VIPER" Chemotherapy in Rel/Ref DLBCL PHASE2 Objectives
The primary objective of this study is to:
• determine the com...
Show More Location
Weill Cornell Medical College
Learn More & Join Trial